These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 24928441)

  • 41. Long noncoding RNA TUG1 is downregulated in non-small cell lung cancer and can regulate CELF1 on binding to PRC2.
    Lin PC; Huang HD; Chang CC; Chang YS; Yen JC; Lee CC; Chang WH; Liu TC; Chang JG
    BMC Cancer; 2016 Aug; 16():583. PubMed ID: 27485439
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic polymorphisms in the polycomb group gene EZH2 and the risk of lung cancer.
    Yoon KA; Gil HJ; Han J; Park J; Lee JS
    J Thorac Oncol; 2010 Jan; 5(1):10-6. PubMed ID: 19901851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Long non-coding RNA HOTAIR promotes tumor cell invasion and metastasis by recruiting EZH2 and repressing E-cadherin in oral squamous cell carcinoma.
    Wu Y; Zhang L; Zhang L; Wang Y; Li H; Ren X; Wei F; Yu W; Liu T; Wang X; Zhou X; Yu J; Hao X
    Int J Oncol; 2015; 46(6):2586-94. PubMed ID: 25901533
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selective inhibition of EZH2 by ZLD1039 blocks H3K27 methylation and leads to potent anti-tumor activity in breast cancer.
    Song X; Gao T; Wang N; Feng Q; You X; Ye T; Lei Q; Zhu Y; Xiong M; Xia Y; Yang F; Shi Y; Wei Y; Zhang L; Yu L
    Sci Rep; 2016 Feb; 6():20864. PubMed ID: 26868841
    [TBL] [Abstract][Full Text] [Related]  

  • 45. H3K27me3 may be associated with Oct4 and Sox2 in mouse preimplantation embryos.
    Wu FR; Zhang Y; Ding B; Lei XH; Huang JC; Wang CH; Liu Y; Wang R; Li WY
    Genet Mol Res; 2014 Dec; 13(4):10121-9. PubMed ID: 25501223
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Genome-wide transcriptional profiling analysis reveals annexin A6 as a novel EZH2 target gene involving gastric cellular proliferation.
    Qi Y; Zhang X; Kang Y; Wu J; Chen J; Li H; Guo Y; Liu B; Shao Z; Zhao X
    Mol Biosyst; 2015 Jul; 11(7):1980-6. PubMed ID: 25947258
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phosphorylation of EZH2 by AMPK Suppresses PRC2 Methyltransferase Activity and Oncogenic Function.
    Wan L; Xu K; Wei Y; Zhang J; Han T; Fry C; Zhang Z; Wang YV; Huang L; Yuan M; Xia W; Chang WC; Huang WC; Liu CL; Chang YC; Liu J; Wu Y; Jin VX; Dai X; Guo J; Liu J; Jiang S; Li J; Asara JM; Brown M; Hung MC; Wei W
    Mol Cell; 2018 Jan; 69(2):279-291.e5. PubMed ID: 29351847
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Polycomb repressive complex's evolutionary conserved function: the role of EZH2 status and cellular background.
    Gall TroĊĦelj K; Novak Kujundzic R; Ugarkovic D
    Clin Epigenetics; 2016; 8():55. PubMed ID: 27239242
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The histone H3K27 methylation mark regulates intestinal epithelial cell density-dependent proliferation and the inflammatory response.
    Turgeon N; Blais M; Delabre JF; Asselin C
    J Cell Biochem; 2013 May; 114(5):1203-15. PubMed ID: 23192652
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The knock-down of overexpressed EZH2 and BMI-1 does not prevent osteosarcoma growth.
    Sasaki H; Setoguchi T; Matsunoshita Y; Gao H; Hirotsu M; Komiya S
    Oncol Rep; 2010 Mar; 23(3):677-84. PubMed ID: 20127006
    [TBL] [Abstract][Full Text] [Related]  

  • 51. EZH2 Inhibition Blocks Multiple Myeloma Cell Growth through Upregulation of Epithelial Tumor Suppressor Genes.
    Hernando H; Gelato KA; Lesche R; Beckmann G; Koehr S; Otto S; Steigemann P; Stresemann C
    Mol Cancer Ther; 2016 Feb; 15(2):287-98. PubMed ID: 26590165
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The transcriptional repressor NIPP1 is an essential player in EZH2-mediated gene silencing.
    Nuytten M; Beke L; Van Eynde A; Ceulemans H; Beullens M; Van Hummelen P; Fuks F; Bollen M
    Oncogene; 2008 Feb; 27(10):1449-60. PubMed ID: 17724462
    [TBL] [Abstract][Full Text] [Related]  

  • 53. EZH1 in germ cells safeguards the function of PRC2 during spermatogenesis.
    Mu W; Starmer J; Shibata Y; Yee D; Magnuson T
    Dev Biol; 2017 Apr; 424(2):198-207. PubMed ID: 28254491
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BMP2 inhibits cell proliferation by downregulating EZH2 in gastric cancer.
    Chen Z; Yuan L; Li X; Yu J; Xu Z
    Cell Cycle; 2022 Nov; 21(21):2298-2308. PubMed ID: 35856444
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The polycomb group protein enhancer of zeste 2 is a novel therapeutic target for cervical cancer.
    Ding M; Zhang H; Li Z; Wang C; Chen J; Shi L; Xu D; Gao Y
    Clin Exp Pharmacol Physiol; 2015 May; 42(5):458-64. PubMed ID: 25739318
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Roles of enhancer of zeste homolog 2: from skeletal muscle differentiation to rhabdomyosarcoma carcinogenesis.
    Marchesi I; Giordano A; Bagella L
    Cell Cycle; 2014; 13(4):516-27. PubMed ID: 24496329
    [TBL] [Abstract][Full Text] [Related]  

  • 57. p38-mediated phosphorylation at T367 induces EZH2 cytoplasmic localization to promote breast cancer metastasis.
    Anwar T; Arellano-Garcia C; Ropa J; Chen YC; Kim HS; Yoon E; Grigsby S; Basrur V; Nesvizhskii AI; Muntean A; Gonzalez ME; Kidwell KM; Nikolovska-Coleska Z; Kleer CG
    Nat Commun; 2018 Jul; 9(1):2801. PubMed ID: 30022044
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Epigenetic reprogramming in solid tumors: therapeutic implications of EZH2 gain-of-function mutations.
    Barsotti AM; Ryskin M; Rollins RA
    Epigenomics; 2015 Aug; 7(5):687-90. PubMed ID: 26317265
    [No Abstract]   [Full Text] [Related]  

  • 59. Mutual regulation between CHD5 and EZH2 in hepatocellular carcinoma.
    Xie CR; Li Z; Sun HG; Wang FQ; Sun Y; Zhao WX; Zhang S; Zhao WX; Wang XM; Yin ZY
    Oncotarget; 2015 Dec; 6(38):40940-52. PubMed ID: 26517514
    [TBL] [Abstract][Full Text] [Related]  

  • 60. JARID2 is involved in transforming growth factor-beta-induced epithelial-mesenchymal transition of lung and colon cancer cell lines.
    Tange S; Oktyabri D; Terashima M; Ishimura A; Suzuki T
    PLoS One; 2014; 9(12):e115684. PubMed ID: 25542019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.